title: Regression of liver metastases after treatment with oxaliplatin/capecitabine and development of a progressive multifocal leukoencephalopathy in a patient with advanced thymoma.
authors.affiliation: University Hospital Bonn, Bonn, Germany.
authors.forename: Annkristin
authors.initials: A
authors.lastname: Heine
authors.forename: Alexandra
authors.initials: A
authors.lastname: Schmiedel
authors.forename: Thomas
authors.initials: T
authors.lastname: Menschik
authors.forename: Stefanie Andrea Erika
authors.initials: SA
authors.lastname: Held
authors.forename: Christoph
authors.initials: C
authors.lastname: Erdmann
authors.forename: Peter
authors.initials: P
authors.lastname: Brossart
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy* / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D012074:Remission Induction; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil